Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01911650 · ClinicalTrials.gov registry record · NA
A Pilot Study: Treatment of Achilles Tendinopathy With Platelet-Rich Plasma Therapy
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01911650: Completed NA study, sponsored by University of Wisconsin, Madison.
NCT01911650 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01911650, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The overall goal of this proposal is to correlate ultrasound elastography technique with more standard clinically based outcome measures within the setting of a small sample sized group of patients affected by moderate-to- severe, chronic (\>6months) midsubstance Achilles tendinopathy (AT).
Primary Outcome
Primary outcome measure: Estimate ultrasound based changes consistent with disease modification in two ways: 1. conventional ultrasound to assess Achilles tendon thickness, neovascularity, and hypoechogenicity. 2. estimate AE and SWI variability and the correlations of AE and SWI with conventional ultrasound measures to plan future research.
Interventions
- OTHER Quality of Life Questionnaires
- OTHER Autologous Platelet Rich Plasma
- OTHER Ultrasound Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-06 |
| Est. Completion | 2019-01-10 |
| Phase | NA |
What the finished NCT01911650 record still lists
NCT01911650 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Quality of Life Questionnaires is the first listed.
NCT01911650 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01911650 about?
NCT01911650 is a clinical study titled "A Pilot Study: Treatment of Achilles Tendinopathy With Platelet-Rich Plasma Therapy". The overall goal of this proposal is to correlate ultrasound elastography technique with more standard clinically based outcome measures within the setting of a small sample sized group of patients affected by moderate-to- severe, chronic (\>6months) midsubstance Achilles tendinopathy (AT).
What is the current status of trial NCT01911650?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2013-06. Estimated completion is 2019-01-10.
What interventions are being tested in trial NCT01911650?
The interventions under investigation include: Quality of Life Questionnaires (OTHER), Autologous Platelet Rich Plasma (OTHER), Ultrasound Imaging (OTHER).
Who is sponsoring clinical trial NCT01911650?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01911650's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia